Description
Dolutegravir, emtricitabine and tenofovir alafenamide tablets are indicated for use alone as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 40 kg
| Strength | 50 mg |
| Pack Size | Box |
| Brand | Kocitaf |
| Packaging Type | Bottle |
| Composition | Not specified |
| Form | Not specified |
| Shelf Life | Not specified |
| Usages | Not specified |
| Country of Origin | Not specified |
